Japan· JP-1249009D1030
エペリゾン塩酸塩
A eperison product containing エペリゾン塩酸塩, registered in Japan by エーザイ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- エペリゾン塩酸塩
- Manufacturer
- エーザイ
- Country
- Japan (JP)
- ATC code
- M03BX09
- ATC class
- Eperison
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under M03BX09
Eperison, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bb8aca92-c88b-4a51-9c26-cdc6e2b9da42 GET /v1/drugs/bb8aca92-c88b-4a51-9c26-cdc6e2b9da42?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１０％１ｇ",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1249009D1030",
"category": "内用薬",
"price_yen": 24.7,
"generic_name": "エペリゾン塩酸塩",
"product_name_jp": null,
"therapeutic_class": "1249",
"transitional_expiry": null
}See everything about eperison.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.